NCT06943001 Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents
| NCT ID | NCT06943001 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor College of Medicine |
| Condition | Obesity and Type 2 Diabetes |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-04-12 |
| Primary Completion | 2026-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-04-12 with a primary completion date of 2026-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Hispanic adolescents are disproportionately burdened by type 2 diabetes (T2D). Social determinants of health (SDoH) serve as barriers to behavior change and participation in disease prevention efforts, especially among vulnerable adolescents. Telehealth is a potentially effective approach for delivering disease prevention programs as it addresses some SDoH like transportation, childcare needs, and parent work schedules. Unfortunately, there are no theory- or evidence-based telehealth diabetes prevention program for Hispanic adolescents. Therefore the purpose of this study is to adapt an evidence-based diabetes prevention program for delivery via telehealth and to test the feasibility of this study among Hispanic adolescents (12-16 years) with obesity.
Eligibility Criteria
Inclusion Criteria: * Self-report as Hispanic * obese, defined as body mass index percentile (BMI%) ≥ 95th percentile * ages of 12-16 years * owns his or her own cellphone Exclusion Criteria: * Taking a medication (i.e. steroids) or diagnosed with a condition (i.e. sleep apnea) that influences activity, sleep, and/or cognition * Recent hospitalization or injury that prevents normal physical activity * Pregnant * Currently enrolled in an exercise program or currently using a personal activity monitoring device like Fitbit * Taking medications or diagnosed with a condition that influences activity, glucose metabolism, and/or cognition.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06943001 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 16 Years, studying Obesity and Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06943001 currently recruiting?
Yes, NCT06943001 is actively recruiting participants. Contact the research team at soltero@bcm.edu for enrollment information.
Where is the NCT06943001 trial being conducted?
This trial is being conducted at Houston, United States.
Who is sponsoring the NCT06943001 clinical trial?
NCT06943001 is sponsored by Baylor College of Medicine. The trial plans to enroll 40 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.